HEMOSHEAR, LLC

Basic Information

1115 5TH ST SW
CHARLOTTESVILLE, VA, 22902-6465

Company Profile

n/a

Additional Details

Field Value
DUNS: 809452217
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of an iPSC-derived human vascular system for drug discovery and devel

    Amount: $249,013.00

    DESCRIPTION (provided by applicant): R43 SBIR: Development of an iPSC-derived human vascular system for drug development. ABSTRACT Human inducible pluripotent stem cells (iPSCs) can be differentiated ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Development of an iPSC-derived human hepatocyte platform for drug development.

    Amount: $281,942.00

    DESCRIPTION (provided by applicant): Human inducible pluripotent stem cells (iPSCs) proliferate readily and can be terminally differentiated into hepatocytes, which potentially makes them an attractiv ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Development of a human hepatocyte predictive pharmacology and toxicology system.

    Amount: $1,584,146.00

    DESCRIPTION (provided by applicant): There is a critical need to improve the accuracy of preclinical drug efficacy and toxicity screening and testing through the development of human hepatocyte (liver ...

    SBIR Phase II 2013 Department of Health and Human Services
  4. TOPIC 314: DEVELOPMENT OF HUMAN TISSUE CULTURE SYSTEM THAT MIMICS THE TUMOR MICRO

    Amount: $298,547.00

    Not Available

    SBIR Phase I 2013 Department of Health and Human Services
  5. Hemodynamic Co-Culture Liver Model for Drug Discovery and Assessment

    Amount: $190,786.00

    DESCRIPTION (provided by applicant): Drug developers desperately need better tools in the laboratory to improve the 90% failure rate of drugs in clinical trials. Liver toxicity is still the leading ca ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. Creating a predictive vascular system for early development

    Amount: $4,293,883.00

    DESCRIPTION (provided by applicant): The frequent inability of in vitro assays and animal models to accurately predict human response to a new drug candidate results in costly drug development failure ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. Genome-wide profiling of human vascular response to oxidized lipoprotreins

    Amount: $166,830.00

    DESCRIPTION (provided by applicant): Atherosclerosis is a vascular inflammatory disease characterized by dramatic changes in endothelial cell (EC) and smooth muscle cell (SMC) phenotypes. The progres ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government